This is not the most recent version of the article. View current version (25 FEB 2016)

Intervention Review

You have free access to this content

Calcium channel blockers for primary Raynaud's phenomenon

  1. Holly Ennis1,
  2. Marina E Anderson2,
  3. Jack Wilkinson3,
  4. Ariane L Herrick1,*

Editorial Group: Cochrane Vascular Group

Published Online: 30 JAN 2014

Assessed as up-to-date: 8 FEB 2013

DOI: 10.1002/14651858.CD002069.pub4


How to Cite

Ennis H, Anderson ME, Wilkinson J, Herrick AL. Calcium channel blockers for primary Raynaud's phenomenon. Cochrane Database of Systematic Reviews 2014, Issue 1. Art. No.: CD002069. DOI: 10.1002/14651858.CD002069.pub4.

Author Information

  1. 1

    University of Manchester, Manchester Academic Health Science Centre, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, Manchester, UK

  2. 2

    University of Liverpool, Institute of Ageing and Chronic Disease, Liverpool, UK

  3. 3

    University of Manchester, Manchester Academic Health Science Centre, Biostatistics, Institute of Population Health, Manchester, UK

*Ariane L Herrick, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, University of Manchester, Manchester Academic Health Science Centre, Stopford Building, Oxford Road, Manchester, M13 9PT, UK. ariane.herrick@manchester.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 30 JAN 2014

SEARCH

This is not the most recent version of the article. View current version (25 FEB 2016)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lauren B. McCaffrey, Heather A. Brandling-Bennett, Kate O. Khorsand, Joy Lynn Mombourguette, Rebecca S. Kunder, Grace S. Sun, Nina T. Washington, Regina-Celeste Ahmad, Shelley Yang, Fan Liu, Alexander Fogel, Joyce M. C. Teng, Therapy in Pediatric Dermatology, 2017,

    CrossRef

  2. 2
    J.E. Beare, L. Curtis-Whitchurch, A.J. LeBlanc, J.B. Hoying, Reference Module in Biomedical Sciences, 2017,

    CrossRef

  3. 3
    I. Silva, G. Teixeira, M. Bertão, R. Almeida, A. Mansilha, C. Vasconcelos, Raynaud phenomenon, Reviews in Vascular Medicine, 2016, 4-5, 9

    CrossRef

  4. 4
    Graham Wilfred Ewing, Case Study: The Determination of a Complex Multi-Systemic Medical Condition by a Cognitive, Virtual Scanning Technique, Case Reports in Clinical Medicine, 2015, 04, 06, 209

    CrossRef

  5. 5
    Michael Hughes, Voon H. Ong, Marina E. Anderson, Frances Hall, Pia Moinzadeh, Bridget Griffiths, Eileen Baildam, Christopher P. Denton, Ariane L. Herrick, Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis, Rheumatology, 2015, 54, 11, 2015

    CrossRef

  6. 6
    Fredrick M. Wigley, Ariane L. Herrick, Management of Raynaud’s Phenomenon and Digital Ulcers, Current Treatment Options in Rheumatology, 2015, 1, 1, 68

    CrossRef

  7. 7
    Michael Hughes, Amir Snapir, Jack Wilkinson, Daniel Snapir, Fredrick M. Wigley, Ariane L. Herrick, Prediction and impact of attacks of Raynaud’s phenomenon, as judged by patient perception, Rheumatology, 2015, 54, 8, 1443

    CrossRef

  8. 8
    Holly Ennis, Michael Hughes, Marina E Anderson, Jack Wilkinson, Ariane L Herrick, Calcium channel blockers for primary Raynaud's phenomenon, The Cochrane Library,